FDA Devices recall · Reported November 17, 2021
Ellume COVID-19 Home Test
Due to a higher rate of false positive test results.
Ellume LTD recalled Ellume COVID-19 Home Test - a critical-severity action.
Ellume COVID-19 Home Test was recalled by Ellume LTD in November 17, 2021. Reason: Due to a higher rate of false positive test results.. Check the official notice for the remedy. Verify recall #Z-0183-2022 with the FDA Devices before acting.
The recall
Ellume LTD issued this critical-severity FDA Devices recall-Due to a higher rate of false positive test results..
- Critical
- severity level
- Class I
- classification
- November 17, 2021
- reported
Sourced from official FDA Devices enforcement records. Verify recall #Z-0183-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
Recall Insight
This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Medical Devices recalls over time
Where this recall sits in its category - 41,021 medical devices recalls on record
Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Product description
Ellume COVID-19 Home Test
Reason for recall
Due to a higher rate of false positive test results.
Recall Profile
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Ongoing |
| Recall number | Z-0183-2022 |
| Date reported | November 17, 2021 |
| Date initiated | October 1, 2021 |
| Recalling firm | Ellume LTD |
| Firm location | East Brisbane, N/A |
| Affected scope | 427,994 kits |
| Distribution | U.S.: MN, NY, PA, RI, UT, WA. O.U.S.: Not provided |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
- Check the recall number (Z-0183-2022) and product description against the item you own. Search the archive
- Confirm the current status with FDA Devices before acting, recall details can be updated.
- This is a Class I (high-risk) recall, stop using the product immediately and follow the disposal or return instructions. What to do next
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Frequently Asked Questions
What product was recalled? ▼
Why was this product recalled? ▼
Which agency issued this recall? ▼
Where was the recalled product distributed? ▼
Should I stop using a recalled medication or medical device? ▼
Nationwide recalls with similar severity or category timing
Drug and device notices outside this firm and state, matched by severity timing and product category.
Similar severity · nearest report date
Same archive severity grade (Critical), closest by report date among other firms and states.
Similar Medical Devices · nearest report date
Same product category, closest by report date among other firms and states (deduped against the severity set).
Compare this recall with GORE VIABIL Short Wire Biliary Endoprosthesis, Model No. VS… → · All Medical Devices recalls
Methodology · Corrections · Archive as of August 2026